Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by Chapman Investment Management LLC

Chapman Investment Management LLC raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,174 shares of the medical equipment provider’s stock after purchasing an additional 117 shares during the quarter. Intuitive Surgical accounts for 0.8% of Chapman Investment Management LLC’s investment portfolio, making the stock its 22nd biggest holding. Chapman Investment Management LLC’s holdings in Intuitive Surgical were worth $1,135,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also modified their holdings of the stock. M.E. Allison & CO. Inc. acquired a new stake in Intuitive Surgical in the fourth quarter valued at about $449,000. Seilern Investment Management Ltd acquired a new stake in Intuitive Surgical in the fourth quarter valued at $82,517,000. Sycomore Asset Management grew its stake in shares of Intuitive Surgical by 27.4% during the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after purchasing an additional 4,079 shares during the period. Exome Asset Management LLC lifted its stake in shares of Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after purchasing an additional 1,069 shares during the period. Finally, China Universal Asset Management Co. Ltd. grew its position in Intuitive Surgical by 5.6% during the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after buying an additional 525 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 0.9 %

ISRG stock opened at $601.17 on Wednesday. The stock has a 50-day moving average price of $561.88 and a two-hundred day moving average price of $522.27. The company has a market cap of $214.12 billion, a PE ratio of 93.79, a price-to-earnings-growth ratio of 5.74 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00.

Insider Transactions at Intuitive Surgical

In related news, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. This represents a 6.39 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Jamie Samath sold 108 shares of the firm’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,746,819.42. This trade represents a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 6,348 shares of company stock worth $3,587,582. 0.80% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the company. Truist Financial upped their price target on Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Leerink Partners lifted their target price on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Citigroup raised their price objective on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Jefferies Financial Group upped their target price on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Finally, Raymond James boosted their price target on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average price target of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.